Status:
TERMINATED
Prevention of Seroma Following Inguinal Lymph Node Dissection With Prophylactic Incisional Negative Pressure Wound Therapy
Lead Sponsor:
Odense University Hospital
Conditions:
Seroma
Surgical Site Infection
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Inguinal lymph node dissection (ILND) is indicated following metastatic malignant melanoma, and is associated with a high-complication rate, of which many begin with the formation of seroma and ends i...
Eligibility Criteria
Inclusion
- All malignant melanoma patients who are candidates for ILND and 18 years of age or older
Exclusion
- Patients suspected of having tumor residuals after ILND, previous groin irradiation or patients suffering from dementia or any psychiatric disorder making them incapable of informed consent or adherence to follow up, along with patients who are unable to communicate in Danish or English will not be included in the study.
Key Trial Info
Start Date :
April 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2020
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT03433937
Start Date
April 1 2018
End Date
September 1 2020
Last Update
June 29 2021
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Dept. of Plastic Surgery, Rigshospitalet
Copenhagen, Denmark
2
Dept. of Plastic Surgery, Herlev Gentofte Hospital
Herlev, Denmark
3
Dept. of Plastic Surgery, Odense University Hospital
Odense, Denmark
4
Dept. of Plastic Surgery, Roskilde Hospital
Roskilde, Denmark